Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Andrology

  Free Subscription


Articles published in Int J Urol

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    October 2018
  1. KITTA T
    Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- an
    Int J Urol. 2018 Oct 25. doi: 10.1111/iju.13833.
    PubMed     Text format    


  2. ZHANG Z, Li H, Zhang X, Dai Y, et al
    Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controll
    Int J Urol. 2018 Oct 25. doi: 10.1111/iju.13828.
    PubMed     Text format     Abstract available


  3. KOBORI Y, Ota S, Okada H, Tanaka T, et al
    Investigation of treatment for azoospermia due to male hypogonadotropic hypogonadism in Japan.
    Int J Urol. 2018 Oct 9. doi: 10.1111/iju.13823.
    PubMed     Text format    


    September 2018
  4. TANAKA T, Masumori N
    Re: Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Int J Urol. 2018 Sep 30. doi: 10.1111/iju.13810.
    PubMed     Text format    


  5. KAWAHARA T
    Editorial Comment to Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men.
    Int J Urol. 2018 Sep 25. doi: 10.1111/iju.13798.
    PubMed     Text format    


  6. HAQUE N, Masumori N, Sakamoto S, Ye Z, et al
    Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men.
    Int J Urol. 2018 Sep 9. doi: 10.1111/iju.13785.
    PubMed     Text format     Abstract available


  7. BECKER B, Witte M, Gross AJ, Netsch C, et al
    Iatrogenic hypospadias classification: A new way to classify hypospadias caused by long-term catheterization.
    Int J Urol. 2018 Sep 2. doi: 10.1111/iju.13791.
    PubMed     Text format    


  8. KURODA S
    Editorial Comment from Dr Kuroda to Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
    Int J Urol. 2018;25:825.
    PubMed     Text format    


    August 2018
  9. NAMEKAWA T
    Editorial Comment to Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
    Int J Urol. 2018 Aug 1. doi: 10.1111/iju.13765.
    PubMed     Text format    


  10. ICHIHARA K, Masumori N, Iwasawa A, Taguchi K, et al
    Silodosin as second-line alpha-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study.
    Int J Urol. 2018 Aug 1. doi: 10.1111/iju.13757.
    PubMed     Text format     Abstract available


    July 2018
  11. SHIRAISHI T, Nakamura T, Ukimura O
    Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol. 2018 Jul 17. doi: 10.1111/iju.13720.
    PubMed     Text format     Abstract available


  12. CHOKESUWATTANASKUL R, Thongprayoon C, Pachariyanon P, Sharma K, et al
    Erectile dysfunction and atrial fibrillation: A systematic review and meta-analysis.
    Int J Urol. 2018 Jul 16. doi: 10.1111/iju.13725.
    PubMed     Text format     Abstract available


  13. HAMANO I, Hatakeyama S, Nakamura R, Fukuhara R, et al
    Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
    Int J Urol. 2018 Jul 2. doi: 10.1111/iju.13732.
    PubMed     Text format     Abstract available


    June 2018
  14. KISHIDA T
    Editorial Comment to Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Int J Urol. 2018 Jun 4. doi: 10.1111/iju.13712.
    PubMed     Text format    


  15. MORIYA K
    Editorial Comment to Width proportion of the urethral plate to the glans can serve as an appraisal index of the urethral plate in hypospadias repair.
    Int J Urol. 2018 Jun 3. doi: 10.1111/iju.13710.
    PubMed     Text format    


    May 2018
  16. INOUE Y, Nakamura T, Nakanishi H, Oishi M, et al
    Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Int J Urol. 2018 May 11. doi: 10.1111/iju.13597.
    PubMed     Text format     Abstract available


  17. RU W, Shen J, Tang D, Xu S, et al
    Width proportion of the urethral plate to the glans can serve as an appraisal index of the urethral plate in hypospadias repair.
    Int J Urol. 2018 May 1. doi: 10.1111/iju.13585.
    PubMed     Text format     Abstract available


  18. HISASUE SI
    Editorial Comment to High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
    Int J Urol. 2018;25:462-463.
    PubMed     Text format    


    April 2018
  19. TAKESHITA H, Kawakami S, Kagawa M, Yano A, et al
    Limited influence of dutasteride on individual prostate-specific antigen variability in men with clinical benign prostatic hyperplasia.
    Int J Urol. 2018 Apr 25. doi: 10.1111/iju.13557.
    PubMed     Text format    


    March 2018
  20. KOYANAGI T
    ACU lecture: One-stage hypospadias repair - Future is Asia the East.
    Int J Urol. 2018 Mar 25. doi: 10.1111/iju.13548.
    PubMed     Text format    


    February 2018
  21. KUROBE M, Kawai K, Suetomi T, Iwamoto T, et al
    High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
    Int J Urol. 2018 Feb 25. doi: 10.1111/iju.13537.
    PubMed     Text format     Abstract available


  22. SHIGEMURA K, Fujisawa M
    Editorial Comment to Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era.
    Int J Urol. 2018;25:110-111.
    PubMed     Text format    


    January 2018
  23. FUKAWA T, Kanayama HO
    Current knowledge of risk factors for testicular germ cell tumors.
    Int J Urol. 2018 Jan 17. doi: 10.1111/iju.13519.
    PubMed     Text format     Abstract available


  24. TAKEI A, Sakamoto S, Wakai K, Tamura T, et al
    Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy.
    Int J Urol. 2018 Jan 11. doi: 10.1111/iju.13521.
    PubMed     Text format     Abstract available


    November 2017
  25. MATSUKAWA Y, Majima T, Matsuo K, Funahashi Y, et al
    Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Int J Urol. 2017 Nov 22. doi: 10.1111/iju.13489.
    PubMed     Text format     Abstract available


  26. YOKOYAMA O, Ozeki A, Suzuki N, Murakami M, et al
    Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
    Int J Urol. 2017 Nov 1. doi: 10.1111/iju.13487.
    PubMed     Text format     Abstract available


    October 2017
  27. TANIGUCHI H, Matsuda T, Nakaoka Y, Morimoto Y, et al
    Health-related quality of life in infertile couples receiving testicular sperm extraction treatment.
    Int J Urol. 2017 Oct 28. doi: 10.1111/iju.13484.
    PubMed     Text format    


  28. HIRASAWA Y, Kato Y, Fujita K
    Age and prostate volume are risk factors for transient urinary incontinence after transurethral enucleation with bipolar for benign prostatic hyperplasia.
    Int J Urol. 2017 Oct 3. doi: 10.1111/iju.13472.
    PubMed     Text format     Abstract available


    August 2017
  29. TOKURA Y, Kobayashi M, Kusakabe T, Kamai T, et al
    Case of hydrocele testis caused by vaginalitis, a rare manifestation of immunoglobulin G4-related disease.
    Int J Urol. 2017 Aug 15. doi: 10.1111/iju.13430.
    PubMed     Text format     Abstract available


  30. SHINDO T
    Editorial Comment to Case of hydrocele testis caused by vaginalitis, a rare manifestation of immunoglobulin G4-related disease.
    Int J Urol. 2017 Aug 15. doi: 10.1111/iju.13438.
    PubMed     Text format    


    July 2017
  31. HOMMA Y, Gotoh M, Kawauchi A, Kojima Y, et al
    Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.
    Int J Urol. 2017 Jul 26. doi: 10.1111/iju.13401.
    PubMed     Text format     Abstract available


  32. FUKUHARA S
    Editorial Comment to Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13418.
    PubMed     Text format    


    June 2017
  33. SATO Y, Otani T, Amano T, Araki T, et al
    Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
    Int J Urol. 2017 Jun 18. doi: 10.1111/iju.13392.
    PubMed     Text format     Abstract available


  34. SHIGEMURA K, Fujisawa M
    Editorial Comment to Substitution urethroplasty using oral mucosa graft for male anterior urethral stricture disease: Current topics and reviews.
    Int J Urol. 2017 Jun 18. doi: 10.1111/iju.13398.
    PubMed     Text format    


  35. HORIGUCHI A
    Substitution urethroplasty using oral mucosa graft for male anterior urethral stricture disease: Current topics and reviews.
    Int J Urol. 2017 Jun 10. doi: 10.1111/iju.13356.
    PubMed     Text format     Abstract available


  36. NOMURA H
    Editorial Comment to Surgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan, 2014 update.
    Int J Urol. 2017;24:477-478.
    PubMed     Text format    


    May 2017
  37. TAKEDA M, Yokoyama O, Yoshida M, Nishizawa O, et al
    Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study.
    Int J Urol. 2017 May 26. doi: 10.1111/iju.13357.
    PubMed     Text format     Abstract available


  38. PUPPO V, Sharif H
    Premature ejaculation is not a disease.
    Int J Urol. 2017 May 26. doi: 10.1111/iju.13384.
    PubMed     Text format    


  39. HORIGUCHI A
    Editorial Comment to Bulbomembranous anastomotic urethroplasty for strictures of the proximal bulbar urethra unassociated with pelvic trauma.
    Int J Urol. 2017 May 6. doi: 10.1111/iju.13366.
    PubMed     Text format    


  40. YUASA T
    Editorial Comment to Identification of risk factors predicting febrile neutropenia in patients with metastatic germ cell tumors receiving cisplatin-based combination chemotherapy.
    Int J Urol. 2017 May 6. doi: 10.1111/iju.13365.
    PubMed     Text format    


  41. FENNER V, Benamran DA, Tran SN, Venzi G, et al
    Bulbomembranous anastomotic urethroplasty for strictures of the proximal bulbar urethra unassociated with pelvic trauma.
    Int J Urol. 2017 May 3. doi: 10.1111/iju.13347.
    PubMed     Text format    


  42. YAMANISHI T, Asakura H, Seki N, Tokunaga S, et al
    Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT St
    Int J Urol. 2017 May 2. doi: 10.1111/iju.13359.
    PubMed     Text format     Abstract available


    April 2017
  43. TAKAMORI H, Masumori N, Kamoto T
    Surgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan, 2014 update.
    Int J Urol. 2017 Apr 21. doi: 10.1111/iju.13344.
    PubMed     Text format    


  44. NISHIKAWA M, Miyake H, Fujisawa M
    Identification of risk factors predicting febrile neutropenia in patients with metastatic germ cell tumors receiving cisplatin-based combination chemotherapy.
    Int J Urol. 2017 Apr 18. doi: 10.1111/iju.13352.
    PubMed     Text format     Abstract available


    February 2017
  45. TAKESHITA H, Kawakami S, Yano A, Okada Y, et al
    Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen >10 ng/mL and those having baseline prostate-specific ant
    Int J Urol. 2017 Feb 16. doi: 10.1111/iju.13284.
    PubMed     Text format    


  46. ZHU Y, Zeng Q
    Re: Resiniferatoxin for treatment of lifelong premature ejaculation: A preliminary study.
    Int J Urol. 2017 Feb 16. doi: 10.1111/iju.13283.
    PubMed     Text format    


  47. SHI B
    Response to Re: Resiniferatoxin for treatment of lifelong premature ejaculation: A preliminary study.
    Int J Urol. 2017 Feb 1. doi: 10.1111/iju.13288.
    PubMed     Text format    


  48. FOO KT
    From evidence-based medicine to evidence-balanced medicine for individualized and personalized care: As applied to benign prostatic hyperplasia/male lower urinary tract symptoms.
    Int J Urol. 2017;24:94-95.
    PubMed     Text format    


  49. SHIGEMURA K, Fujisawa M
    Editorial Comment to From evidence-based medicine to evidence-balanced medicine for individualized and personalized care: As applied to benign prostatic hyperplasia/male lower urinary tract symptoms.
    Int J Urol. 2017;24:95-96.
    PubMed     Text format    


    January 2017
  50. KISHIDA T
    Editorial Comment to Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol. 2017 Jan 13. doi: 10.1111/iju.13275.
    PubMed     Text format    


    December 2016
  51. KAWAI T, Tanaka Y
    Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol. 2016 Dec 4. doi: 10.1111/iju.13268.
    PubMed     Text format     Abstract available


  52. IBRAHIM E
    Editorial Comment from Dr Ibrahim to Testicular sperm extraction for patients with spinal cord injury-related anejaculation: A single-center experience.
    Int J Urol. 2016;23:1027-1028.
    PubMed     Text format    


    November 2016
  53. KANTO S
    Editorial Comment from Dr Kanto to Testicular sperm extraction for patients with spinal cord injury-related anejaculation: A single-center experience.
    Int J Urol. 2016 Nov 8. doi: 10.1111/iju.13257.
    PubMed     Text format    


    October 2016
  54. IWAHATA T, Shin T, Shimomura Y, Suzuki K, et al
    Testicular sperm extraction for patients with spinal cord injury-related anejaculation: A single-center experience.
    Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13226.
    PubMed     Text format     Abstract available


  55. MARTIN C, Nolen H, Podolnick J, Wang R, et al
    Current and emerging therapies in premature ejaculation: Where we are coming from, where we are going.
    Int J Urol. 2016 Oct 5. doi: 10.1111/iju.13202.
    PubMed     Text format     Abstract available


    April 2016
  56. ITO S, Hanaoka N, Shimuta K, Seike K, et al
    Male non-gonococcal urethritis: From microbiological etiologies to demographic and clinical features.
    Int J Urol. 2016;23:325-31.
    PubMed     Text format     Abstract available


  57. SHIRAISHI K, Oka S, Matsuyama H
    Surgical comparison of subinguinal and high inguinal microsurgical varicocelectomy for adolescent varicocele.
    Int J Urol. 2016;23:338-42.
    PubMed     Text format     Abstract available


    March 2016
  58. HAYASHI H, Mochizuki T, Sanjo H, Komiya A, et al
    Clinical application of neutrophil CD64 quantification for differential diagnosis of acute scrotum.
    Int J Urol. 2016;23:266-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: